Glycemic variability

There are 71 papers on glycemic variability in aging research: 28 trials and 25 observational studies in people, 2 in animals, 15 reviews. The newest story, Nov 21, 2026: “Early eating reduced body fat more in morning-oriented adults”.

Biomarker

71 papers study it76 more mention it54 findings

18 new papers in 30 daysSee all 147 papers on glycemic variability

At a glance

Greater glycemic variability is linked with worse cognition, frailty in ICU patients, and higher mortality after acute myocardial infarction or during sepsis in human observational studies. Human trials report reductions with acarbose; a trial of saxagliptin added to metformin shows no clear effect compared with acarbose–metformin.

54 findings in 44 papers from 2010 to 2026, 18 of them since April 2026

“CV, SD, and MAGE increased with the growing age and diabetes duration”
Developing CGMap—Characterizing Continuous Glucose Monitoring Data in Patients with Type 2 DiabetesADA Scientific Sessions 2025 abstract2025doi:10.2337/db25-1006-p
  • Human trial28
  • Humans25
  • Animals2

Interventions

17

Acarbose

downin humans2

2 studies
  1. Acarbose decreases glycemic variability in humans (add-on to metformin, compared with sitagliptin add-on) (22.44 ± 5.08% vs 23.96 ± 5.19%).

    Human trialadd-on to metformin, compared with sitagliptin add-on100 mg three times daily28 daysn = 701

  2. Acarbose decreases glycemic variability in humans (21.88% [18.81%, 25.10%] vs. 23.71% [20.07%, 27.12%]).

    Human trial28 daysn = 710

  3. Acarbose decreases glycemic variability in humans during continuous glucose monitoring periods.

    Human trialduring continuous glucose monitoring periods50 mg1 weekfemalesn = 11

More on Acarbose

Time-restricted feeding

upin humans1

1 study
  1. Time-restricted feeding increases glycemic variability in humans (morning chronotype adults with overweight or obesity).

    Human trialmorning chronotype adults with overweight or obesityearly06:00h-14:00h eating window12 weeks

    Early eating reduced body fat more in morning-oriented adults

    medRxivPreprint

More on Time-restricted feeding

Personalized diet

downin humans1

1 study
  1. Personalized diet decreases glycemic variability in humans (Slightly greater decrease).

    Human trialCompared with standard low-fat, high-fiber diet alongside metformin initiation in prediabetes or early type 2 diabetes6 monthsn = 138

More on Personalized diet

Dapagliflozin

upin dogs1

1 study
  1. Dapagliflozin increases glycemic variability in dogs (naturally occurring diabetes mellitus; ongoing insulin therapy).

    Animalsnaturally occurring diabetes mellitus; ongoing insulin therapycompounded liquid oral formulationshort-termn = 6

More on Dapagliflozin

Step reduction

upin humans1

1 study
  1. Step reduction increases glycemic variability in humans (healthy adults; elevation persisted during recovery).

    Human trialhealthy adults; elevation persisted during recoveryvia e-scooter~33% step reduction7 days, followed by 7 days of recoveryn = 12

More on Step reduction

Continuous glucose monitoring-guided interventions

downin humans1

1 study
  1. Continuous glucose monitoring-guided interventions decrease glycemic variability in humans (prediabetes).

    Reviewprediabetes

More on Continuous glucose monitoring-guided interventions

Solanum tuberosum

upin humans1

1 study
  1. Solanum tuberosum increases glycemic variability in humans (co-ingested with rice (SP + R) replacing one-third of rice carbohydrates).

    Human trialco-ingested with rice (SP + R) replacing one-third of rice carbohydrates

More on Solanum tuberosum

Caloric restriction

downin F. catus1

1 study
  1. Caloric restriction decreases glycemic variability in overweight diabetic cats not achieving remission (-45% (95% CI, 26-65) vs -7% (P = .01)).

    Animalsin overweight diabetic cats not achieving remission12 weeks

More on Caloric restriction

Low-carbohydrate diet

downin humans1

1 study
  1. Low-carbohydrate diet decreases glycemic variability in hospitalized patients with insulin-deficient diabetes (p = 0.03).

    Human trialin hospitalized patients with insulin-deficient diabetesn = 359

More on Low-carbohydrate diet

Semaglutide

downin humans1

1 study
  1. Semaglutide decreases glycemic variability in humans (add-on to SGLT2i and metformin).

    Human trialadd-on to SGLT2i and metforminoraltwo weeksn = 10

More on Semaglutide

Dulaglutide + insulin degludec

downin humans1

1 study
  1. Dulaglutide + insulin degludec decreases glycemic variability in humans (versus basal-bolus insulin at week 16) (%CV 32.2 to 29.0% vs 33.5 to 33.7% in controls; between-group difference -3.04% (95% CI -5.70 to -0.39)).

    Human trialversus basal-bolus insulin at week 16once weekly dulaglutide plus once daily insulin degludec16 weeks

More on Dulaglutide + insulin degludec

Collagen peptides

upin humans1

1 study
  1. Collagen peptides increase glycemic variability in humans (95%CI: 0.0, 0.2 mmol/L; p-value = 0.011).

    Human trialporcine-derived10 gfour weeksn = 56

More on Collagen peptides

COVID-19 vaccine

no changein humans1

1 study
  1. COVID-19 vaccine showed no clear effect on glycemic variability in humans (type 1 diabetes mellitus).

    Human trialtype 1 diabetes mellitus7 daysn = 20

More on COVID-19 vaccine

Teneligliptin

downin humans1

1 study
  1. Teneligliptin decreases glycemic variability in humans (elderly type 2 diabetes mellitus).

    Human trialelderly type 2 diabetes mellitus20 mg12 weeksn = 65

More on Teneligliptin

Saxagliptin

no changein humans1

1 study
  1. Saxagliptin showed no clear effect on glycemic variability in humans (as add-on to metformin, compared with acarbose-metformin).

    Human trialas add-on to metformin, compared with acarbose-metformin

More on Saxagliptin

All 17

Effects

3

Delirium risk reclassification

upin humans1

1 study
  1. Glycemic variability is linked with better delirium risk reclassification in humans (Addition to prediction models for critically ill patients).

    HumansAddition to prediction models for critically ill patientsn = 16,335

    Blood sugar swings linked to sudden confusion in older patients

    Diabetology & metabolic syndrome

Cognitive function

downin humans1

1 study
  1. Glycemic variability is linked with worse cognitive function in humans.

    Humans

Wake-up time

downin humans1

1 study
  1. Glycemic variability is linked with lower wake-up time in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.02 h per 1 mg/dL increase).

    Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388

More on Wake-up time

Upstream

3

Objective sleep dimensions

no changein humans1

1 study
  1. Objective sleep dimensions were not clearly linked with glycemic variability in humans (nondiabetic pregnancy (16-22 weeks gestation)).

    Humansnondiabetic pregnancy (16-22 weeks gestation)femalesn = 55

Wake-up time

downin humans1

1 study
  1. Wake-up time is linked with lower glycemic variability in humans (free-living adults with overweight or obesity at risk of type 2 diabetes) (B = -0.24 mg/dL per 1 h delay).

    Humansfree-living adults with overweight or obesity at risk of type 2 diabetes14 daysn = 388

More on Wake-up time

TCF7L2

no changein humans1

1 study
  1. TCF7L2 was not clearly linked with glycemic variability in humans (without diabetes).

    Humanswithout diabetes72-hour periodn = 235

More on TCF7L2

Associations

25

Mortality

upin humans3downin humans1HR 0.57–1.76

3 studies
  1. Glycemic variability is associated with mortality in humans (Hospitalized patients with type 2 diabetes) (HR = 1.02, 95% CI 1.00–1.04; p = 0.019).

    HumansHospitalized patients with type 2 diabetesOne yearfemales

  2. Glycemic variability is linked with a lower risk of mortality in humans (CV ≤36% against the recommended CGM target; adjusted model) (HR 0.57 [0.32; 0.99]).

    HumansCV ≤36% against the recommended CGM target; adjusted modelmedian 44 months follow-upn = 141

  3. Glycemic variability is linked with a higher risk of mortality in humans (HR 1.76 [1.21; 2.56] per IQR% increase).

    Humansadjusted for age, sex, HbA1c, kidney function, geriatric status and metformin use; per IQR% increasemedian 44 months follow-upn = 141

  4. Glycemic variability is linked with a higher risk of mortality in humans (sepsis) (HR = 1.149, 95% CI 1.07-1.227).

    Humanssepsis90-day

Delirium

upin humans2OR 1.122–1.42

2 studies
  1. Glycemic variability is associated with delirium in humans (OR 1.42, 95% CI 1.18-1.71).

    HumansCritically ill patients; highest versus lowest glycemic variability quartile, fully adjustedn = 16,335

    Blood sugar swings linked to sudden confusion in older patients

    Diabetology & metabolic syndrome
  2. Glycemic variability is linked with a higher risk of delirium in humans (sepsis) (OR = 1.122, 95% CI 1.023-1.230).

    Humanssepsis

More on Delirium

Daily fluctuations in carbohydrate intake

upin humans1

1 study
  1. Daily fluctuations in carbohydrate intake predicts glycemic variability in humans (sedentary adults with central or general obesity; within-person fluctuations) (Standard deviation β=0.004; coefficient of variation β=0.060; largest amplitude of glycemic excursions β=0.011).

    Humanssedentary adults with central or general obesity; within-person fluctuations7–14 daysn = 99

More on Daily fluctuations in carbohydrate intake

Chronic diabetes complications

upin humans1+41% higher risk

1 study
  1. Glycemic variability is associated with chronic diabetes complications in humans (Type 2 diabetes; high glycemic variability phenotype) (41% higher risk).

    HumansType 2 diabetes; high glycemic variability phenotype

More on Chronic diabetes complications

Acute diabetes complications

upin humans1+75% higher risk

1 study
  1. Glycemic variability is associated with acute diabetes complications in humans (Type 2 diabetes; high glycemic variability phenotype) (75% higher risk).

    HumansType 2 diabetes; high glycemic variability phenotype

More on Acute diabetes complications

Pectoralis muscle index

downin humans1

1 study
  1. Glycemic variability is associated with pectoralis muscle index in humans (type 2 diabetes mellitus) (all P < 0.05).

    Humanstype 2 diabetes mellituspectoralis musclen = 303

More on Pectoralis muscle index

Prediabetes

upin humans1

1 study
  1. Prediabetes are associated with glycemic variability in humans (versus normal glucose tolerance) (CV 0.16 vs 0.10; SD 16 vs 10 mg/dL; peak 151 vs 126 mg/dL; TAR 12 vs 0.2%).

    Humansversus normal glucose tolerance

More on Prediabetes

Low skeletal muscle mass

upin humans1OR 1.36

1 study
  1. Glycemic variability is linked with a higher risk of low skeletal muscle mass in hospitalized T2DM patients (OR = 1.36, p < 0.05).

    Humansin hospitalized T2DM patients7-dayn = 614

Cortisol 60 minutes after awakening

upin humans1

1 study
  1. Glycemic variability is associated with cortisol 60 minutes after awakening in humans (Healthy young adults).

    HumansHealthy young adultsn = 32

More on Cortisol 60 minutes after awakening

MMI-system

upin humans1

1 study
  1. MMI-system is associated with glycemic variability in humans (independent of diabetes status).

    Humansindependent of diabetes status12 yearsn = 1,398

More on MMI-system

Body mass index

downin humans1

1 study
  1. Body mass index is associated with glycemic variability in patients with type 2 diabetes.

    Human trialin patients with type 2 diabetes

More on Body mass index

Age

upin humans1

1 study
  1. Age is associated with glycemic variability in patients with type 2 diabetes.

    Human trialin patients with type 2 diabetes

All 25

Funding

1 grant since 2024

Japan Society for the Promotion of Science¥4.6M

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 5Feb 2026: 4Mar 2026: 16Apr 2026: 6May 2026: 5Jun 2026: 13Jul 2026: 0Aug 2026: 13Sep 2026: 3Oct 2026: 7Nov 2026: 1185 papers in 12 months
medRxiv

Early eating reduced body fat more in morning-oriented adults

In a 12-week randomized trial, morning-oriented adults with overweight or obesity lost more body fat with early eating than with later eating or three daily meals.In a 12-week randomized trial, morning-oriented adults with overweight or obesity lost more body fat with early eating than with later eating or three daily meals.

Preprint: randomized trialInterventions
Diabetology & Metabolic Syndrome

Blood sugar swings linked to sudden confusion in older patients

Delirium occurred in 41.8% of the highest blood sugar variability group versus 28.7% of the lowest among older intensive care patients.Delirium occurred in 41.8% of the highest blood sugar variability group versus 28.7% of the lowest among older intensive care patients.

Cohort · 16,335 peoplePopulations

See all 147 papers on glycemic variability